Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:46 PM
Study NCT ID:
NCT03542721
Status:
UNKNOWN
Last Update Posted:
2018-06-04
First Post:
2018-05-18
Brief Title:
Effect of DA-5515 Circulan Soft Cap in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
Sponsor:
Dong-A Pharmaceutical
Organization:
Dong-A Pharmaceutical
Study Overview
Official Title:
A Placebo-controlled Randomized Double-blind Parallel Multi-center Clinical Trial to Evaluate the Efficacy and Safety of DA-5515 Circulan Soft Cap in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation
Status:
UNKNOWN
Status Verified Date:
2018-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the present clinical study is to evaluate the efficacy and safety of the DA-5515 Circulan Soft Cap in patients with chronic fatigue symptoms due to impaired blood circulation
Detailed Description:
This study is conducting to assess the efficacy and safety of the DA-5515 Circulan Soft Cap which has been known to have a fatigue recovery effect due to impaired blood circulation
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None